## ProPublica, Philadelphia Inquirer Probe Compensation Gaps for Opioid Victims as Purdue, Mallinckrodt, Endo Trusts Face Scrutiny
Journalists at ProPublica and The Philadelphia Inquirer have launched an investigation into how individual opioid victims are navigating the court-appointed compensation systems established by three major pharmaceutical manufacturers. Reporters Craig R. McCoy, a veteran corruption correspondent, and Bob Fernandez, an investigative business reporter, are seeking firsthand accounts from those who have pursued payment from trusts funded by Purdue Pharma, Mallinckrodt, and Endo. The reporting team previously examined the Endo bankruptcy proceedings and most recently scrutinized Purdue's revised bankruptcy strategy and its impact on victim compensation.

The inquiry centers on the tens of billions of prescription opioid pills distributed throughout the United States during the crisis, which spurred widespread addiction and health harm. Each of the three manufacturers has funneled resources into court-supervised trusts designed to compensate victims, though the effectiveness and accessibility of these mechanisms remain under examination. Purdue's restructuring plan, which has already attracted significant legal and public attention, forms a focal point of the current investigation.

McCoy and Fernandez are inviting individuals who have sought payment from these trusts to share their experiences. Their work signals ongoing scrutiny of corporate accountability mechanisms in the pharmaceutical sector, particularly regarding whether settlement structures deliver meaningful relief to those who suffered harm. The investigation aims to document the practical realities victims face when navigating compensation processes funded by companies at the center of the opioid epidemic.
---
- **Source**: ProPublica Health
- **Sector**: The Vault
- **Tags**: opioid crisis, Purdue Pharma, Mallinckrodt, Endo, pharmaceutical settlements
- **Credibility**: unverified
- **Published**: 2026-04-23 09:54:10
- **ID**: 76314
- **URL**: https://whisperx.ai/en/intel/76314